<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

James Petricek

20+ years operational and management consulting experience in orthobiologics and regenerative medicine with roles in product development, marketing and business development. Prior management positions with BioMimetic Therapeutics and Synthes.

Regenerative Medicine

OrthoBio-Focused Themes Emerging from NASS 2022

Observations and analysis from the 37th Annual North American Spine Society (NASS) Meeting held October ...

Orthobiologics

Ending on a Bright Note: Q122 OrthoBio Market Recap

Q122 started slow but ended on a bright note as COVID-19 concerns faded and surgical volumes approached ...

Orthobiologics

COVID-19 Headwinds: Q321 OrthoBio Market Recap

Renewed COVID-19 headwinds mute overall Q3 results, however, the soft tissue repair segment remains resi...